Genetic and Epigenetic Determinants of Response to Fluorouracil-based Adjuvant Chemotherapy in Patients With Stage III Colorectal Cancer
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03127111 |
Recruitment Status :
Not yet recruiting
First Posted : April 25, 2017
Last Update Posted : March 15, 2022
|
Sponsor:
Renmin Hospital of Wuhan University
Information provided by (Responsible Party):
Tao Fu, Renmin Hospital of Wuhan University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Not yet recruiting |
---|---|
Estimated Primary Completion Date : | December 31, 2025 |
Estimated Study Completion Date : | December 31, 2026 |
Publications: